Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
      Description

      To learn if giving elranatamab before and after an autologous stem cell transplant (ASTC) can help to control newly diagnosed, high-risk MM. An ASTC is a type of transplant in which a person's own stem cells are collected, preserved, and returned to them.

      Conditions
      Multiple MyelomaPost-transplant MRD-guided Maintenance TherapyPre-transplant Purging
      Talk to us